ALDR
Alder Biopharmaceuticals, Inc.
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
127 hedge funds and large institutions have $1.06B invested in Alder Biopharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 55 increasing their positions, 24 reducing their positions, and 13 closing their positions.
Holders
127
Holders Change
+4
Holders Change %
+3.25%
% of All Funds
2.76%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
20
Increased
55
Reduced
24
Closed
13
Calls
$1.15M
Puts
$1.16M
Net Calls
-$10K
Net Calls Change
-$387K
Top Buyers
| 1 |
BG
1
Bellevue Group
Kuesnacht,
Switzerland
|
$48.5M |
| 2 |
2
Marshall Wace
London,
United Kingdom
|
$19.7M |
| 3 |
3
BlackRock
New York
|
$81.7M |
| 4 |
4
VOYA Investment Management
Atlanta,
Georgia
|
$9.02M |
| 5 |
5
Goldman Sachs
New York
|
$45.3M |
